Stockreport

Lin BioScience Receives U.S. FDA Fast Track Designation For LBS-007 [Yahoo! Finance]

Belite Bio, Inc - American Depositary Shares  (BLTE) 
PDF LBS-007 is the Company's investigational medicinal product for the treatment of acute leukemia A Phase 1/2 trial in patients with relapsed or resistant acute leukemia [Read more]